Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Medicine|May 22, 2023
Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohortRuolan Xia, Yanying Li, Ling Yang, et al.
Molecular Biomedicine|December 14, 2022
The role of Hedgehog and Notch signaling pathway in cancerRuolan Xia, Maosen Xu, Jing Yang, et al.
Frontiers in Oncology|April 29, 2021
Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New DevelopmentsRuolan Xia, Yuwen Zhou, Yuqing Wang, et al.
Molecular Cancer|November 3, 2022
Targeting the tumor stroma for cancer therapyMaosen Xu, Tao Zhang, Ruolan Xia, et al.
Frontiers in Molecular Biosciences|December 24, 2021
Ikaros Proteins in Tumor: Current Perspectives and New DevelopmentsRuolan Xia, Yuan Cheng, Xuejiao Han, et al.
Technology in Cancer Research & Treatment|June 30, 2022
Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-DatabaseYuqing Wang, Yuwen Zhou, Yueyun Chen, et al.
Cell Proliferation|August 31, 2021
Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targetingMaosen Xu, Yang Wang, Ruolan Xia, et al.
Frontiers in Public Health|March 20, 2023
Game-based learning in medical educationMaosen Xu, Yong Luo, Yu Zhang, et al.
Clinical Medicine Insights. Oncology|December 6, 2021
Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New DevelopmentKe Cheng, Yuqing Wang, Yuwen Zhou, et al.
International Immunopharmacology|December 28, 2020
Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancerYuwen Zhou, Ruolan Xia, Huilang Xiao, et al.
Pageof 2